Filed: 2/14/2024ACC: 0001172661-24-001436
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 34 equity positions with a total reported market value of $586.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
34
Positions
$586.73M
Total AUM (reported)
39.42M
Total Shares
Allocation by class
COM$456.28M77.8%
COM NEW$44.44M7.6%
SHS$24.27M4.1%
ADS$20.02M3.4%
SPONSORED ADS$16.59M2.8%
CLASS A ORD SHS$15.39M2.6%
COM PAR $.01$7.00M1.2%
Portfolio Concentration
Top 3$151.64M25.8%
4–10$189.33M32.3%
11–25$216.80M37.0%
Rest$28.95M4.9%
Top 3 weight
25.8%
Top 10 weight
58.1%
Voting Authority Distribution
Total shares with voting rights: 39.42M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
39.42M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other34
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings34
Rows:
ALPINE IMMUNE SCIENCES INC
DFNDShares3.70M
TypeSH
Market value$70.59M
12.03%
Sole
0.00
Shared
3.70M
None
0.00
CYTOKINETICS INC
DFNDShares500K
TypeSH
Market value$41.74M
7.11%
Sole
0.00
Shared
500K
None
0.00
UROGEN PHARMA LTD
DFNDShares2.62M
TypeSH
Market value$39.31M
6.70%
Sole
0.00
Shared
2.62M
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares1.82M
TypeSH
Market value$33.02M
5.63%
Sole
0.00
Shared
1.82M
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares648K
TypeSH
Market value$30.99M
5.28%
Sole
0.00
Shared
648K
None
0.00
XENON PHARMACEUTICALS INC
DFNDShares600K
TypeSH
Market value$27.64M
4.71%
Sole
0.00
Shared
600K
None
0.00
RAPT THERAPEUTICS INC
DFNDShares1.10M
TypeSH
Market value$27.33M
4.66%
Sole
0.00
Shared
1.10M
None
0.00
ALKERMES PLC
DFNDShares875.04K
TypeSH
Market value$24.27M
4.14%
Sole
0.00
Shared
875.04K
None
0.00
AEROVATE THERAPEUTICS INC
DFNDShares1.04M
TypeSH
Market value$23.48M
4.00%
Sole
0.00
Shared
1.04M
None
0.00
VAXCYTE INC
DFNDShares360K
TypeSH
Market value$22.61M
3.85%
Sole
0.00
Shared
360K
None
0.00
EVOLUS INC
DFNDShares2M
TypeSH
Market value$21.06M
3.59%
Sole
0.00
Shared
2M
None
0.00
ANAPTYSBIO INC
DFNDShares976.98K
TypeSH
Market value$20.93M
3.57%
Sole
0.00
Shared
976.98K
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares293K
TypeSH
Market value$20.02M
3.41%
Sole
0.00
Shared
293K
None
0.00
NEUROGENE INC
DFNDShares994.23K
TypeSH
Market value$19.27M
3.28%
Sole
0.00
Shared
994.23K
None
0.00
AMICUS THERAPEUTICS INC
DFNDShares1.28M
TypeSH
Market value$18.17M
3.10%
Sole
0.00
Shared
1.28M
None
0.00
TOURMALINE BIO INC
DFNDShares672.88K
TypeSH
Market value$17.62M
3.00%
Sole
0.00
Shared
672.88K
None
0.00
ABIVAX SA
DFNDShares1.55M
TypeSH
Market value$16.59M
2.83%
Sole
0.00
Shared
1.55M
None
0.00
ZURA BIO LTD
DFNDShares3.29M
TypeSH
Market value$15.39M
2.62%
Sole
0.00
Shared
3.29M
None
0.00
OPTINOSE INC
DFNDShares8.84M
TypeSH
Market value$11.40M
1.94%
Sole
0.00
Shared
8.84M
None
0.00
APOGEE THERAPEUTICS INC
DFNDShares400K
TypeSH
Market value$11.18M
1.90%
Sole
0.00
Shared
400K
None
0.00
ARVINAS INC
DFNDShares234.08K
TypeSH
Market value$9.63M
1.64%
Sole
0.00
Shared
234.08K
None
0.00
KARUNA THERAPEUTICS INC
DFNDShares30.25K
TypeSH
Market value$9.57M
1.63%
Sole
0.00
Shared
30.25K
None
0.00
VISTAGEN THERAPEUTICS INC
DFNDShares1.86M
TypeSH
Market value$9.55M
1.63%
Sole
0.00
Shared
1.86M
None
0.00
TERNS PHARMACEUTICALS INC
DFNDShares1.31M
TypeSH
Market value$8.50M
1.45%
Sole
0.00
Shared
1.31M
None
0.00
INTRA-CELLULAR THERAPIES INC
DFNDShares110.61K
TypeSH
Market value$7.92M
1.35%
Sole
0.00
Shared
110.61K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALPINE IMMUNE SCIENCES INCDFND | COM | 3.70M | SH | $70.59M 12.03% | 0.00 | 3.70M | 0.00 |
CYTOKINETICS INCDFND | COM NEW | 500K | SH | $41.74M 7.11% | 0.00 | 500K | 0.00 |
UROGEN PHARMA LTDDFND | COM | 2.62M | SH | $39.31M 6.70% | 0.00 | 2.62M | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 1.82M | SH | $33.02M 5.63% | 0.00 | 1.82M | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 648K | SH | $30.99M 5.28% | 0.00 | 648K | 0.00 |
XENON PHARMACEUTICALS INCDFND | COM | 600K | SH | $27.64M 4.71% | 0.00 | 600K | 0.00 |
RAPT THERAPEUTICS INCDFND | COM | 1.10M | SH | $27.33M 4.66% | 0.00 | 1.10M | 0.00 |
ALKERMES PLCDFND | SHS | 875.04K | SH | $24.27M 4.14% | 0.00 | 875.04K | 0.00 |
AEROVATE THERAPEUTICS INCDFND | COM | 1.04M | SH | $23.48M 4.00% | 0.00 | 1.04M | 0.00 |
VAXCYTE INCDFND | COM | 360K | SH | $22.61M 3.85% | 0.00 | 360K | 0.00 |
EVOLUS INCDFND | COM | 2M | SH | $21.06M 3.59% | 0.00 | 2M | 0.00 |
ANAPTYSBIO INCDFND | COM | 976.98K | SH | $20.93M 3.57% | 0.00 | 976.98K | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 293K | SH | $20.02M 3.41% | 0.00 | 293K | 0.00 |
NEUROGENE INCDFND | COM | 994.23K | SH | $19.27M 3.28% | 0.00 | 994.23K | 0.00 |
AMICUS THERAPEUTICS INCDFND | COM | 1.28M | SH | $18.17M 3.10% | 0.00 | 1.28M | 0.00 |
TOURMALINE BIO INCDFND | COM | 672.88K | SH | $17.62M 3.00% | 0.00 | 672.88K | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 1.55M | SH | $16.59M 2.83% | 0.00 | 1.55M | 0.00 |
ZURA BIO LTDDFND | CLASS A ORD SHS | 3.29M | SH | $15.39M 2.62% | 0.00 | 3.29M | 0.00 |
OPTINOSE INCDFND | COM | 8.84M | SH | $11.40M 1.94% | 0.00 | 8.84M | 0.00 |
APOGEE THERAPEUTICS INCDFND | COM | 400K | SH | $11.18M 1.90% | 0.00 | 400K | 0.00 |
ARVINAS INCDFND | COM | 234.08K | SH | $9.63M 1.64% | 0.00 | 234.08K | 0.00 |
KARUNA THERAPEUTICS INCDFND | COM | 30.25K | SH | $9.57M 1.63% | 0.00 | 30.25K | 0.00 |
VISTAGEN THERAPEUTICS INCDFND | COM | 1.86M | SH | $9.55M 1.63% | 0.00 | 1.86M | 0.00 |
TERNS PHARMACEUTICALS INCDFND | COM | 1.31M | SH | $8.50M 1.45% | 0.00 | 1.31M | 0.00 |
INTRA-CELLULAR THERAPIES INCDFND | COM | 110.61K | SH | $7.92M 1.35% | 0.00 | 110.61K | 0.00 |
Page 1 of 2